| |
| |
|
| Insider
Information: |
Wilson Troy Edward |
| Relationship: |
Director |
| City: |
Los Angeles |
| State: |
CA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
4 |
|
| Direct
Shares |
93,642 |
|
|
Indirect Shares
|
974,552 |
|
|
| Direct
Value |
$1,986,808 |
|
|
|
Indirect Value
|
$24,757,364 |
|
|
| Total
Shares |
1,068,194 |
|
|
| Total
Value |
$26,744,172 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
2
|
|
Stock
price went up :
|
0
|
1
|
| Stock
price went down : |
0
|
1
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -67.5%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Puma Biotechnology Inc |
PBYI |
Director |
2023-06-13 |
27,350 |
2023-06-13 |
550 |
Premium* |
|
|
Kura Oncology Inc |
KURA |
|
2024-01-24 |
559 |
2024-01-24 |
579,194 |
Premium* |
|
|
Zosano Pharma Corp |
ZSAN |
Director |
2015-04-01 |
3,000 |
2015-04-01 |
0 |
Premium* |
|
|
Avidity Biosciences, Inc. |
RNA |
Director |
2023-12-12 |
62,733 |
2023-12-12 |
394,808 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
65 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 3 of 3
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2020-06-11 |
4 |
S |
$9.97 |
$251,693 |
D/D |
(25,245) |
26,098 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-08-19 |
4 |
AS |
$22.09 |
$263,196 |
D/D |
(11,913) |
28,096 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-08-17 |
4 |
AS |
$22.00 |
$283,868 |
D/D |
(12,901) |
28,096 |
0 |
% |
|
| PBYI |
Puma Biotechnology Inc |
Director |
– • – |
2021-06-10 |
4 |
S |
$11.36 |
$292,433 |
D/D |
(25,748) |
350 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-10-08 |
4 |
OE |
$6.15 |
$309,776 |
D/D |
50,370 |
78,466 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-09-11 |
4 |
AS |
$28.00 |
$501,928 |
D/D |
(17,926) |
28,096 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2024-01-24 |
4 |
OE |
$4.80 |
$550,594 |
D/D |
91,052 |
84,666 |
0 |
- |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-09-10 |
4 |
AS |
$28.00 |
$1,036,840 |
D/D |
(37,030) |
28,096 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-08-17 |
4 |
AS |
$22.00 |
$1,100,000 |
I/I |
(50,000) |
356,736 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-09-08 |
4 |
AS |
$26.00 |
$1,300,000 |
I/I |
(50,000) |
306,736 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-10-08 |
4 |
AS |
$34.00 |
$1,712,580 |
D/D |
(50,370) |
28,096 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2024-01-24 |
4 |
AS |
$20.23 |
$1,841,982 |
D/D |
(91,052) |
559 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-09-14 |
4 |
AS |
$28.82 |
$2,838,876 |
I/I |
(98,490) |
206,736 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-10-07 |
4 |
AS |
$32.00 |
$3,196,800 |
I/I |
(99,900) |
106,736 |
0 |
% |
|
| KURA |
Kura Oncology Inc |
President and CEO |
• • – |
2020-10-08 |
4 |
AS |
$34.00 |
$3,629,024 |
I/I |
(106,736) |
0 |
0 |
% |
|
65 Records found
|
|
Page 3 of 3 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
